A sialosyl sulfonate as a potent inhibitor of influenza virus replication

Org Biomol Chem. 2017 Jun 27;15(25):5249-5253. doi: 10.1039/c7ob00947j.

Abstract

A new direction for influenza virus sialidase inhibitor development was identified using a sulfonate congener of 2-deoxy-2-β-H N-acetylneuraminic acid. Sialosyl sulfonates can be synthesised efficiently in four steps from N-acetylneuraminic acid via a microwave assisted decarboxylation. The presence of the sulfonate group significantly increases inhibition of influenza virus sialidase and viral infection when compared to the carboxylate congener, and also to the benchmark sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid, Neu5Ac2en.

MeSH terms

  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Arylsulfonates / chemical synthesis
  • Arylsulfonates / chemistry
  • Arylsulfonates / pharmacology*
  • Carbohydrate Conformation
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Influenza A virus / drug effects*
  • Neuraminidase / antagonists & inhibitors*
  • Neuraminidase / metabolism
  • Structure-Activity Relationship
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Arylsulfonates
  • Enzyme Inhibitors
  • sialosyl sulfonate
  • Neuraminidase